Semax 10mg
$50.00
Semax is a synthetic heptapeptide analogue of ACTH(4–10) studied for neuroprotective signaling, neurotrophic pathways, and cellular responses in laboratory research.
Certificate of Analysis
Important Notice
Research Use Only. Not for human or animal consumption.
These products are intended exclusively for laboratory and scientific research by qualified professionals. They are not intended for human or veterinary use and are not approved to diagnose, treat, cure, or prevent any disease.
Description
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, derived from the ACTH(4–10) sequence. Research has investigated its activity in neurological and cellular models, including pathways associated with neurotrophic signaling, inflammatory responses, and cellular stress.
Preclinical research has examined Semax in relation to brain-derived neurotrophic factor (BDNF), neuronal signaling, oxidative stress, and responses to experimental cerebral ischemia. These findings have made Semax a subject of interest in neuroscience and neuropeptide research.
Semax is not an FDA-approved drug in the United States. In 2026, the FDA reviewed Semax-related bulk drug substances in the context of potential compounding and noted concerns including potential immunogenicity associated with aggregation and peptide-related impurities.
